Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

University of Pittsburgh Medical Center’s investment and innovation arm has allocated $1bn to drug development funding over the next four years.

UW spinout Nicoya has its sight set on product development and business expansion after a series A round featuring UW Student Venture Fund and Wilfrid Laurier University’s Startup Fund.

Ian Postlethwaite will exit as CEO of NetScientific this July as the embattled commercialisation firm continues to patch up its balance sheet.

GV was among the investors as long-term care support provider CareBridge emerged from stealth with $40m and two acquisitions.

University of Pittsburgh Medical Center’s venture arm has allocated $1bn to drugs, diagnostics and devices development, including a $200m partnership with the university.

Wilson Sonsini Goodrich & Rosati and an undisclosed insurer are among the LPs for the venture firm's new digital health-focused vehicle.

Waters is buying laboratory software developer Andrew Alliance having backed its 2018 series C round with fellow corporates Inpeco and Tecan.

Minsheng Life-backed oncology drug developer Zelgen has priced an initial public offering set to value it at more than $1.1bn.

Cigna's corporate venturing arm led a $29.5m round for population healthcare management platform Arcadia.io and bumped Buoy Health's series B up to $20m.